Rapid-Acting Antidepressants
Current Pharmaceutical Design October 19, 2018 Jeffrey M. Witkin, Daniel E. Knutson, Gabriel J. Rodriguez et al. 44 citations
Background: Conventional antidepressants are thought to produce their impact on clinical symptoms by increasing the central availability of biogenic amine neurotransmitters (the monoamine hypothesis of depression). These drugs continue to be the primary medicines used in major depressive disorder. Although they have biological effects after acute dosing, full antidepressant response generally...